Valuation Indivior Pharmaceuticals, Inc.

Stocks

Market Closed - Nasdaq 16:00:00 2026-10-19 EDT			5-day change	1st Jan Change
33.87 ^USD	+4.38%		-6.07%	-5.60%

09-17	Indivior Pharmaceuticals, Inc. Declares Special Cash Dividend, Payable on or About November 6, 2026	CI
09-17	Indivior Sets Special Cash Dividend at $8.13 a Share Contingent on Completion of Supernus Merger	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	2,423	2,969	2,085	1,553	4,480	3,997	-	-
Change	-	22.54%	-29.76%	-25.5%	188.39%	-10.77%	-	-
Enterprise Value (EV) ¹	1,563	2,435	2,008	1,567	4,604	3,985	3,427	2,806
Change	-	55.81%	-17.52%	-21.95%	193.72%	-13.45%	-13.99%	-18.11%
P/E	12.8x	-57.2x	1,527x	-34.5x	21.9x	9.1x	8.25x	7.54x
PBR	-	59.3x	-	-8.02x	-45.8x	-	-	-
PEG	-	0x	-15x	0x	-0x	0x	0.8x	0.8x
Capitalization / Revenue	3.06x	3.29x	1.91x	1.31x	3.62x	3x	2.86x	2.68x
EV / Revenue	1.98x	2.7x	1.84x	1.32x	3.72x	2.99x	2.45x	1.88x
EV / EBITDA	7.74x	10.8x	6.97x	4.64x	10.8x	5.47x	4.33x	3.26x
EV / EBIT	8.36x	11.5x	7.47x	5.02x	11.1x	5.79x	4.65x	3.53x
EV / FCF	4.61x	-10.7x	-4.86x	-196x	-49.5x	7.83x	6.3x	4.54x
FCF Yield	21.7%	-9.32%	-20.6%	-0.51%	-2.02%	12.8%	15.9%	22%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	1.35	-0.38	0.01	-0.36	1.64	3.72	4.105	4.49
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	791	901	1,093	1,188	1,239	1,332	1,400	1,489
EBITDA ¹	202	225	288	338	428	728.4	790.8	859.6
EBIT ¹	187	212	269	312	415	688.8	737.7	795.7
Net income ¹	205	-53	2	-48	210	474.3	530	582.9
Net Debt ¹	-860	-534	-77	14	124	-12.5	-570	-1,191
Reference price ²	17.25	21.75	15.27	12.43	35.88	33.87	33.87	33.87
Nbr of stocks (in thousands)	140,437	136,489	136,551	124,970	124,854	118,014	-	-
Announcement Date	2/16/22	2/16/23	2/22/24	2/20/25	2/26/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
INDIVIOR PHARMACEUTICALS, INC.	8.72x	2.87x	5.24x	-	3.83B
ELI LILLY AND COMPANY	35.96x	12.96x	27.14x	0.55%	1,120B
JOHNSON & JOHNSON	37.4x	6.3x	17.74x	2.09%	616B
ABBVIE INC.	36.43x	8.36x	17.24x	2.43%	504B
ROCHE HOLDING AG	20.46x	4.99x	12.38x	2.64%	367B
MERCK & CO., INC.	106.52x	5.95x	25.12x	2.33%	360B
NOVARTIS AG	21.18x	5.54x	13.63x	2.88%	288B
ASTRAZENECA PLC	21.7x	4.38x	12.55x	2.01%	258B
AMGEN INC.	27.46x	7.06x	12.64x	2.33%	234B
GILEAD SCIENCES, INC.	-45.63x	6.99x	27.07x	2.11%	194B
Average	27.02x	6.54x	17.08x	2.15%	394.47B
Weighted average by Cap.	34.70x	8.20x	20.02x	1.84%